Orthofix International | OFIX - Operating Profit


Orthofix International reported $-84.62M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
AngioDynamics USD -9.97M 1.12M Feb/2025
AtriCure USD 208K 4.03M Sep/2025
Dexcom USD 242.5M 29.9M Sep/2025
EDAP TMS EUR -5.77M 228K Jun/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Hologic USD 237M 16M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD -84.62M 65.72M Dec/2024
Smith & Nephew USD 440M 50M Dec/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD -408.9M 586.38M Sep/2025
Veracyte USD 23.11M 8.8M Sep/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025